Crimean-Congo hemorrhagic fever in children.
BACKGROUND
Crimean-Congo hemorrhagic fever (CCHF) virus causes a severe disease in humans with a mortality up to 30%. In Turkey there has been an increase in the number of cases during years since 2002. Humans of all ages living in endemic areas,especially those who are working as shepherds and toddlers, have high risk of acquiring CCHF.


OBJECTIVE
The epidemiological, clinical, and laboratory characteristics of the children, who were diagnosed as Crimean-Congo hemorrhagic fever (CCHF) were described.


METHODS
The children infected with CCHF virus between April 2008 and October 2009, and hospitalised in Ankara Dişkapi Children's and Research Hospital were included.


RESULTS
Laboratory diagnosis was set by detection of CCHF IgM antibodies and/or genetic detection of CCHF virus. Thirtyone cases included to the study, and all were from the northeastern Anatolia and the southern parts of Black sea region. The mean age was 9.45+/-4.9 years, the proportion of females was 38.7%. The majority (87%) of the cases had the history of tick bite. There was no fatal case. All the patients had the history of fever. Malaise,tonsillopharyngitis, nausea-vomiting, headache, diarrhea, myalgia and rash were the most common symptoms. The mean AST and ALT levels on the admission were 116 (range 25-389) and 61 (range 8-180)U/L respectively. The mean platelet count on admission was 125,000/mm3, and the lowest was 23,000/mm3. The mean of the lowest white blood cell count was 2353/mm3 and the mean of the highest lactate dehydrogenase was 861IU/L.


CONCLUSIONS
The clinical course of CCHF among children seems to be milder than in adults. Tonsillopharyngitis is a common symptom among children with CCHF.
Tezer
Hasan
H
Department of Pediatrics, Republic of Turkey Ministry of Health Ankara Diskapi Children's and Research Hospital, Diskapi, and Hacettepe University Faculty of Medicine, Ankara, Turkey. hasantezer@yahoo.com
Sucakli
Iclal Ayranci
IA
Sayli
Tulin Revide
TR
Celikel
Elif
E
Yakut
Ibrahim
I
Kara
Ateş
A
Tunc
Bahattin
B
Ergonul
Onder
O
D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D003225:Hemorrhagic Fever Virus, Crimean-Congo / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006479:Hemorrhagic Fever, Crimean / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology*; D006760:Hospitalization; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D008297:Male; D010612:Pharyngitis / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D014069:Tonsillitis / Q000821:virology; D014421:Turkey / Q000453:epidemiology
D000914:Antibodies, Viral; D007075:Immunoglobulin M; D012367:RNA, Viral
Lancet Infect Dis. 2006 Apr;6(4):203-14
16554245
Ann Trop Paediatr. 2009 Mar;29(1):23-8
19222930
Clin Infect Dis. 2003 Oct 15;37(8):1139-42
14523782
J Med Microbiol. 2005 Apr;54(Pt 4):385-389
15770025
Clin Microbiol Infect. 2006 Jun;12(6):551-4
16700704
Pediatr Infect Dis J. 2008 Jun;27(6):561-3
18434934
Infection. 1997 Nov-Dec;25(6):364-7
9427056
Euro Surveill. 2008 Aug 14;13(33):
18761892
J Infect. 2006 Mar;52(3):207-15
15953646
Am J Trop Med Hyg. 1989 Nov;41(5):581-5
2510529
Scand J Infect Dis. 2007;39(4):332-6
17454897
Antiviral Res. 2004 Dec;64(3):145-60
15550268
Int J Infect Dis. 2008 Jul;12(4):374-9
18063402
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S794-800
2749111
Clin Infect Dis. 2004 Jul 15;39(2):284-7
15307042
J Infect. 2009 Oct;59(4):291-3
19665801
Int J Infect Dis. 2009 May;13(3):380-6
18986819
Chest. 2005 Jul;128(1):263-72
16002945